Seamount Financial Group Inc. Sells 312 Shares of Johnson & Johnson (NYSE:JNJ)

Seamount Financial Group Inc. lowered its stake in shares of Johnson & Johnson (NYSE:JNJ) by 6.6% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 4,402 shares of the company’s stock after selling 312 shares during the quarter. Seamount Financial Group Inc.’s holdings in Johnson & Johnson were worth $637,000 as of its most recent SEC filing.

Other large investors have also bought and sold shares of the company. Northstar Group Inc. increased its stake in Johnson & Johnson by 6.1% in the 4th quarter. Northstar Group Inc. now owns 42,503 shares of the company’s stock valued at $6,147,000 after buying an additional 2,450 shares during the last quarter. Capital Management Associates Inc increased its position in shares of Johnson & Johnson by 2.5% during the fourth quarter. Capital Management Associates Inc now owns 9,057 shares of the company’s stock valued at $1,310,000 after acquiring an additional 221 shares during the last quarter. Golden State Wealth Management LLC bought a new stake in Johnson & Johnson during the fourth quarter worth $608,000. Centerline Wealth Advisors LLC purchased a new position in Johnson & Johnson in the fourth quarter worth $213,000. Finally, Live Oak Private Wealth LLC grew its stake in Johnson & Johnson by 1.8% in the 4th quarter. Live Oak Private Wealth LLC now owns 6,743 shares of the company’s stock valued at $975,000 after purchasing an additional 116 shares during the period. 69.55% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on the stock. Wolfe Research began coverage on shares of Johnson & Johnson in a report on Friday, November 15th. They issued an “outperform” rating and a $190.00 price target on the stock. Guggenheim boosted their target price on shares of Johnson & Johnson from $162.00 to $166.00 and gave the company a “neutral” rating in a research note on Monday, February 3rd. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $215.00 price target on shares of Johnson & Johnson in a report on Wednesday, October 16th. Stifel Nicolaus reduced their price objective on Johnson & Johnson from $170.00 to $155.00 and set a “hold” rating for the company in a report on Thursday, January 23rd. Finally, StockNews.com upgraded Johnson & Johnson from a “buy” rating to a “strong-buy” rating in a research note on Saturday, January 25th. Nine analysts have rated the stock with a hold rating, eight have issued a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $170.67.

Johnson & Johnson Stock Performance

Johnson & Johnson stock opened at $154.22 on Tuesday. The firm’s 50 day simple moving average is $147.42 and its 200 day simple moving average is $156.08. The company has a current ratio of 1.03, a quick ratio of 0.79 and a debt-to-equity ratio of 0.45. Johnson & Johnson has a 1-year low of $140.68 and a 1-year high of $168.85. The firm has a market capitalization of $371.31 billion, a PE ratio of 23.19, a price-to-earnings-growth ratio of 2.46 and a beta of 0.52.

Johnson & Johnson (NYSE:JNJ) last posted its quarterly earnings data on Wednesday, January 22nd. The company reported $2.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.99 by $0.05. The company had revenue of $22.52 billion during the quarter, compared to analyst estimates of $22.44 billion. Johnson & Johnson had a return on equity of 34.35% and a net margin of 18.20%. The firm’s quarterly revenue was up 5.3% on a year-over-year basis. During the same quarter last year, the company earned $2.29 earnings per share. As a group, analysts expect that Johnson & Johnson will post 10.58 earnings per share for the current fiscal year.

Johnson & Johnson Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, March 4th. Investors of record on Tuesday, February 18th will be paid a $1.24 dividend. This represents a $4.96 dividend on an annualized basis and a yield of 3.22%. The ex-dividend date is Tuesday, February 18th. Johnson & Johnson’s dividend payout ratio is currently 74.59%.

Insider Buying and Selling at Johnson & Johnson

In related news, Director Mark A. Weinberger acquired 1,000 shares of the stock in a transaction dated Thursday, December 12th. The shares were purchased at an average price of $147.22 per share, for a total transaction of $147,220.00. Following the transaction, the director now owns 1,000 shares in the company, valued at $147,220. This represents a ∞ increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through the SEC website. 0.16% of the stock is currently owned by company insiders.

Johnson & Johnson Profile

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.